CHINA-HEALTH: NEW RESEARCH DISCLOSES 100,000 CHINESE DIED BECAUSE OF REDUNDANT TRIALS ON STATINS
|
A report published by Caixin (February 18) disclosed that new research suggests that "hundreds of Chinese heart disease patients died avoidable deaths, with more still suffering heart attacks and strokes, after 100,000 went untreated in unnecessary trials of widely used medication". It said the figures — from experiments that ran from 2008 to 2019 — emerged in a review of “redundant” Chinese trials on statins, a class of drugs used around the world for more than 30 years to lower cholesterol, by a team at Johns Hopkins University. Their findings were published this month in The BMJ, a peer-reviewed British journal. The team said the number of redundant trials uncovered meant “urgent reform” was needed to protect Chinese patients. The review also found that few of the examined studies reported ethics approval or funding sources.
|